Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status (Descending)
00085-4351-01 00085-4351 Interferon alfa-2b Intron A Immunotherapy Cytokine Interferon Aug. 11, 2014 In Use
00085-4352-01 00085-4352 Interferon alfa-2b Intron A Immunotherapy Cytokine Interferon Aug. 11, 2014 In Use
00115-1408-01 00115-1408 Methyltestosterone Methyltestosterone 10.0 mg/1 Hormonal Therapy Androgen Oral Sept. 21, 2015 In Use
00115-1408-03 00115-1408 Methyltestosterone Methyltestosterone 10.0 mg/1 Hormonal Therapy Androgen Oral Sept. 21, 2015 In Use
00115-1408-08 00115-1408 Methyltestosterone Methyltestosterone 10.0 mg/1 Hormonal Therapy Androgen Oral Sept. 21, 2015 In Use
17478-0327-05 17478-0327 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous May 22, 2014 In Use
17478-0327-45 17478-0327 Zoledronic Acid Zoledronic Acid 4.0 mg/5mL Ancillary Therapy Bisphosphonate Intravenous May 22, 2014 In Use
17478-0546-01 17478-0546 Granisetron Hydrochloride Granisetron Hydrochloride 1.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Oct. 1, 2009 June 1, 2011 In Use
17478-0546-02 17478-0546 Granisetron Hydrochloride Granisetron Hydrochloride 1.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Oct. 1, 2009 In Use
17478-0546-04 17478-0546 Granisetron Hydrochloride Granisetron Hydrochloride 1.0 mg/mL Ancillary Therapy Antiemetic 5HT3 Receptor Antagonist Intravenous Oct. 1, 2009 June 1, 2011 In Use

Found 10,000 results in 10 milliseconds — Export these results